Karen K. Kyuregyan, Dr. Sci. (Biology), Professor
Head of the Laboratory of molecular epidemiology of viral hepatitis, Central Research Institute of Epidemiology, Moscow, Russia; leading researcher at the Laboratory of Viral Hepatitis at Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Scopus h-index — 8
Web of Science h-index — 7
SCOPUS AuthorID, ORCID, Mendeley, ResearchGate
Biography
In 1998 graduated from the biological faculty of the Lobachevsky Nizhny Novgorod State University. In 1998-2001 — PhD student at Gamaleya Research Institute of Microbiology and Epidemiology. In 2001-2006 — Researcher at Gamaleya Research Institute of Microbiology and Epidemiology. In 2006-2016 — head of the laboratory of etiology, diagnostics, epidemiology and prevention of viral hepatitis at Chumakov Institute of Poliomyelitis and Viral Encephalitis, in 2013-2016 — Deputy director for research of the same institute. In 2012 defended his doctoral dissertation "Molecular and biological bases of viral hepatitis control". Professor of the Russian Academy of Sciences since 2016. Since 2016 to 2022 — chief researcher and head of the department for the study of viral hepatitis at the Research Institute of Molecular and Personalized Medicine of the Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia. Since 2023 until the present – head of the laboratory of molecular epidemiology of viral hepatitis at Central Research Institute of Epidemiology of Rospotrebnadzor. Also, since 2016 until present — a leading researcher (part-time) at the Laboratory of Viral Hepatitis at Mechnikov Research Institute of Vaccines and Sera.
Research interests
Study of the etiology, molecular epidemiology of viral hepatitis, the development of a scientifically based system for the prevention of these infections, the development of new diagnostic and vaccine preparations, as well as experimental modeling of viral infections. The study of the circulation of hepatotropic viruses and their genetic diversity under the influence of external factors — vaccination, antiviral therapy, population migration.